polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer (PM 100)

comb-shaped copolymer of PEG derivative and maleic anhydride; mol wt 100,000; structure of comb-shaped copolymers given in first source

Also Known As:

PM 100; activated PM(100)

Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Ethylene Glycols: 8
      - Polyethylene Glycols: 3865
        polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer: 10
- Anhydrides: 241
  - Maleic Anhydrides: 63
    - polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer: 10
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Furans: 85
    - Maleic Anhydrides: 63
      - polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer: 10
Macromolecular Substances: 97
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer: 10
Biomedical and Dental Materials
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer: 10
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyethylene Glycols: 3865
        polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer: 10

Experts

1.	Fonseca, Gabriel: 1 article (06/2022)
2.	Fors, Martha: 1 article (06/2022)
3.	Guerrero-Urbina, Clivia: 1 article (06/2022)
4.	Rodríguez-Guerrero, Marjorie: 1 article (06/2022)
5.	Vásquez, Bélgica: 1 article (06/2022)
6.	Candrinho, Baltazar: 1 article (01/2021)
7.	Chaccour, Carlos: 1 article (01/2021)
8.	Dengela, Dereje: 1 article (01/2021)
9.	Fornadel, Christen: 1 article (01/2021)
10.	Gogue, Christelle: 1 article (01/2021)

Related Diseases

1.	Malaria 01/21/2021 - "The primary malaria vector during the trial was Anopheles funestus sensu lato (s.l.), and standard World Health Organization (WHO) tube tests with this population indicated variable but increasing resistance to pyrethroids (including alpha-cypermethrin, from > 85% mortality in 2017 to 7% mortality in 2018) and uniform susceptibility to PM (100% mortality in both years). "
2.	Dyslipidemias (Dyslipidemia) 01/01/2023 - "When fatty liver, BMI, and dyslipidemia were considered as multiple mediators in the association, hyperuricemia was linked to both prediabetes [tnde: 1.11, 95% CI: 1.04-1.11; tnie: 1.07, 95% CI: 1.05-1.09; and overall proportion mediated (pm): 42%, 95% CI: 27%-73%] and diabetes risk (tnde: 0.96, 95% CI: 0.82-1.14; tnie: 1.25, 95% CI: 1.18-1.33; and pm: 100%, 95% CI: 57%-361%). "
3.	Hyperuricemia 01/01/2023 - "When fatty liver, BMI, and dyslipidemia were considered as multiple mediators in the association, hyperuricemia was linked to both prediabetes [tnde: 1.11, 95% CI: 1.04-1.11; tnie: 1.07, 95% CI: 1.05-1.09; and overall proportion mediated (pm): 42%, 95% CI: 27%-73%] and diabetes risk (tnde: 0.96, 95% CI: 0.82-1.14; tnie: 1.25, 95% CI: 1.18-1.33; and pm: 100%, 95% CI: 57%-361%). "
4.	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 06/01/1994 - "Using non-radiolabeled, commercial Fe-PM no postabsorptive serum iron increase was found after oral Fe-PM (100 mg Fe dosage) in a group of 7 patients with haemorrhagic or posthaemorrhagic iron deficiency anemia. "
5.	Prediabetic State (Prediabetes) 01/01/2023 - "When fatty liver, BMI, and dyslipidemia were considered as multiple mediators in the association, hyperuricemia was linked to both prediabetes [tnde: 1.11, 95% CI: 1.04-1.11; tnie: 1.07, 95% CI: 1.05-1.09; and overall proportion mediated (pm): 42%, 95% CI: 27%-73%] and diabetes risk (tnde: 0.96, 95% CI: 0.82-1.14; tnie: 1.25, 95% CI: 1.18-1.33; and pm: 100%, 95% CI: 57%-361%). "

Related Drugs and Biologics

1.	Pyrethrins (Pyrethroids)
2.	cypermethrin (alphamethrin)
3.	Nitrites
4.	Loperamide (Imodium)
5.	Iron
6.	Bisacodyl (Bicol)